Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 4 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -77.8%, and profit growth estimate of -301.7% for FY25, based on top 4 analyst calls.